About Us
Dr. Nancy Tawil
Chief Scientific Officer
Ph.D in Biomedical Engineering and Phage Expert
Mark Engel
CEO
Mr. Engel has been founding and building life sciences companies since 1990, including NPO Pharmaceuticals (successful exit); Excel PharmaStudies (successful exit); Tiger Medical Group (successful exit); and Haoyisheng (IPO ready). Mr. Engel also has a family fund investing in life science organizations.
Sandy Li
Quality Manager
M.S. in Chemistry. Experienced in GMP
drug production
Bryan Li
EVP Medical
China Medical University graduate, majored in Medicine, certified by American ECFMG, and specialized in Dermatology. Trained and worked at the Dermatology Departments of China Medical University and Guangdong Medical University. Dr. Li was a visiting scholar at the Dermatology Department of Asian University in South Korea and a post-doc research fellow at the Dermatology Department of Boston University, with several publications in peer-reviewed Journals. Mr. Li has nearly 30 years experience in medical and clinical operations at Fortune 500 multinationals.
We are focused on topical bacterial infection since the size of the market is so large and there are virtually no totally effective and affordable solutions. Over time, we will look to in-license other later stage biological dermatological treatments.
